3.Change of ?-amyloid precursor protein processing in platelet of Alzheimer's disease patients
Xiao-Qin HUANG ; Jian-Ping JIA ; Chun-Qiu FAN ; Xiu-Min DONG
Chinese Journal of Neurology 1999;0(06):-
Objective To investigate the characteristic of ?-amyloid precursor protein (A?) processing in activated platelet in AD.Methods Thirty-six sporadic AD patients and 30 control subjects were included in this study.Blood was collected from the subjects to separate platelets.After treated by thrombin,the soluble amyloid precursor protein (APP) level in the snpernatants of platelets from 36 were analyzed by means of western blot with a specific antibody recognizing soluble APP.Meanwhile A? level was measured by radioimmunoassay.Results After treated with thrombin,the level of soluble APP in the supernatants of platelets in patients with AD decreased by 31.0% (P
4.Application quantitative thermal sensory test in facial palsy
Ou-Mei CHENG ; Wei-Wei DONG ; Yong YAN ; Xiu-Shu WU ; Jun YANG ; Qin YANG ;
Chinese Journal of Physical Medicine and Rehabilitation 2003;0(06):-
Objective To investigate quantitatively the thermal sensation characteristics of the patients with facial palsy and the value of quantitative thermal test (QTT) in prognostication.Methods The QTT threshold of the fore ear and cheek of 30 patients with peripheral facial palsy was tested,their facial nerve conduction velocity was measured,and House-Brackmann facial nerve grading system was used to estimate facial nerve function at 2~3 weeks,a month,two months and half a year post onset.Results It was found that 12 out of 30 patients had abnor- mal QTT threshold value;the majority of them suffered from herpes virus and diabetes.In those with abnormal QTT, 8 were with diabetes mellitus (account for 66.7%),3 with partial shingles (account for 25%),and 1 with positive serum virus infection (account for 8.3%).Those with normal QTT were significantly different from those with abnor- mal QTT,with regard to the House-Brackmann rating scores after 2 and 6 months post onset (P
5.The ability of pleth variability index to predict fluid responsiveness in mechanically ventilated patients under general anaesthesia.
Qin-fang CAI ; Wei-dong MI ; Wei-xiu YUAN
Chinese Journal of Surgery 2010;48(21):1628-1632
OBJECTIVETo evaluate the ability of pleth variability index (PVI) in predicting fluid responsiveness in mechanically ventilated patients under general anesthesia.
METHODSFrom August to November 2009, 25 patients were enclosed in this study following anesthesia induction. PVI was continuously displayed by the Masimo Radical 7. All patients were also monitored with Vigileo/FloTrac system. Haemodynamic data such as cardiac index (CI), stroke volume variability (SVV), mean arterial pressure, heart rate, central venous pressure, PVI, perfusion index were recorded before and after volume expansion (hetastar 6%, 7 ml/kg). Fluid responsiveness was defined as an increase in CI ≥ 15% (ΔCI ≥ 15).
RESULTSSVV and PVI were significantly higher in the responders (16.0% ± 2.6% and 20.5% ± 3.7%) than those in non-responders (11.6% ± 1.4% and 13.8% ± 2.6%) respectively (P < 0.05). The SVV threshold of 13.5% before volume expansion was able to discriminate the responders from the non-responders with a sensitivity of 88.2% and a specificity of 87.5%. The threshold for PVI was 15.5%, the same sensitivity of 88.2% and specificity of 87.5% were obtained. There was a significant relationship between PVI before volume expansion and change in CI after volume expansion (r = 0.683, P < 0.01), the same as the changes of SVV (r = 0.600, P < 0.01).
CONCLUSIONPVI as a new dynamic indices can predict fluid responsiveness non-invasively in mechanically ventilated patients during general anesthesia.
Abdomen ; surgery ; Adult ; Aged ; Anesthesia, General ; Female ; Fluid Therapy ; Hemodynamics ; physiology ; Humans ; Male ; Middle Aged ; Monitoring, Intraoperative ; Respiration, Artificial
6.Screening and analysis of coagulation factor VIII inhibitor in patients with hemophilia A.
Ao-Li ZHANG ; Lin-Hua YANG ; Xiu-Er LIU ; Hua ZHAO ; Jian-Hua ZHANG ; Chun-Xia DONG ; Xi-Lin QI ; Xiu-Yu QIN
Journal of Experimental Hematology 2011;19(4):968-970
In order to detect coagulation factor VIII (FVIII) inhibitor in patients with severe hemophilia A (HA) and preliminarily study the genetic mutation in patients with inhibitor positive. Totally 58 patients with HA (FVIII: C < 1%) were enrolled. FVIII: C activity was measured by one-stage coagulation assay. FVIII inhibitor was screened by using APTT method and FVIII inhibitor in screened positive patients with HA was quantitatively analyzed by using Bethesda method. Using genomic DNA as template, 12, 14, 16 exons of FVIII in screened positive patients were amplified, and the mutations of amplified products were detected by direct sequencing. The results indicated that the FVIII inhibitor could be detected in 4 patients (6.9%) from 58 HA patients, no gene mutations in 12, 14, 16 exons of FVIII were found. It is concluded that the positive rate of FVIII inhibitor in HA patients is lower than that reported in literature. The causes of inhibitor production needs to further investigate.
Adolescent
;
Adult
;
Blood Coagulation Factor Inhibitors
;
isolation & purification
;
Blood Coagulation Tests
;
Child
;
Child, Preschool
;
Exons
;
Factor VIII
;
antagonists & inhibitors
;
genetics
;
Genetic Testing
;
Hemophilia A
;
diagnosis
;
genetics
;
Humans
;
Infant
;
Middle Aged
;
Mutation
;
Young Adult
7.Synthesis and antitumor activity of novel tetrahydro-beta-carboline derivatives as KSP inhibitors.
Xiu-Qin RUAN ; Ming CHEN ; Wu-Tong WU ; Qi-Dong YOU
Acta Pharmaceutica Sinica 2013;48(7):1119-1123
Inhibitors of kinesin spindle protein (KSP) are a promising class of anticancer agents that cause mitotic arrest and induce apoptosis of tumor cells. A series of novel tetrahydro-beta-carboline derivatives were synthesized as kinesin spindle protein inhibitor and evaluated as potential antitumor agents. All compounds showed promising KSP inhibitiory activity. Compounds 8 and 9 exhibited better antitumor activity (Lung/A549, Stomach/AGS) than CK0106023 with GI50/IC50 values (1.07/1.62 and 1.46/3.27 micromol x L(-1), 1.09/>10 and 1.22/6.33 micromol x L(-1), respectively).
Antineoplastic Agents
;
chemical synthesis
;
chemistry
;
pharmacology
;
Carbolines
;
chemical synthesis
;
chemistry
;
pharmacology
;
Cell Line, Tumor
;
Cell Proliferation
;
drug effects
;
Humans
;
Inhibitory Concentration 50
;
Kinesin
;
antagonists & inhibitors
;
pharmacology
;
Molecular Structure
8.Determination of mosapride in human plasma by high performance liquid chromatography tandem mass spectrometry.
Feng QIN ; Ling-Yun CHEN ; Yuan-Yuan MA ; Dong WANG ; Juan LIU ; Xiu-Mei LU ; Fa-Mei LI
Acta Pharmaceutica Sinica 2007;42(8):882-885
To develop a sensitive and specific high performance liquid chromatography-tandem mass spectrometric (HPLC-MS/MS) method for the determination of mosapride in human plasma, mosapride and internal standard tamsulosin were extracted from plasma with liquid-liquid extraction, then separated on a Waters ACQUITY UPLC BEH C18 column (50 mm x 2.1 mm, 1.7 microm ID) with gradient elution at flow-rate of 0.25 mL x min(-1). The mobile phase was water (containing 0.3% formic acid) and acetonitrile under gradient conditions. Electrospray ionization (ESI) source was applied and operated in the positive ion mode. Multiple reaction monitoring (MRM) mode with the transitions of m/z 422 --> m/z 198 and m/z 409 --> m/z 228 were used to quantify mosapride and the internal standard, respectively. The linear calibration curve was obtained in the concentration range of 0.17 - 68.00 ng x mL(-1). The lower limit of quantification was 0.17 ng x mL(-1). The inter- and intra-day precision (RSD) was less than 13%, and the accuracy (RE) was within +/- 6.3% calculated from QC samples. The method was used to determine the concentration of mosapride in plasma after a single oral dose of 5 mg mosapride citrate to 20 healthy male Chinese volunteers. The method has been proved to be selective, sensitive, rapid and suitable for pharmacokinetic study of mosapride.
Administration, Oral
;
Area Under Curve
;
Benzamides
;
administration & dosage
;
blood
;
pharmacokinetics
;
Chromatography, High Pressure Liquid
;
methods
;
Gastrointestinal Agents
;
administration & dosage
;
blood
;
pharmacokinetics
;
Humans
;
Male
;
Morpholines
;
administration & dosage
;
blood
;
pharmacokinetics
;
Sensitivity and Specificity
;
Serotonin Receptor Agonists
;
administration & dosage
;
blood
;
pharmacokinetics
;
Spectrometry, Mass, Electrospray Ionization
;
Tandem Mass Spectrometry
;
methods
9.The extended free lateral arm flap for buccal soft tissue reconstruction after buccal cancer.
Yong CHEN ; Xu-Dong YANG ; Wei LI ; Xiu-Juan CHEN ; Qin-Gang HU
Chinese Journal of Plastic Surgery 2013;29(1):22-25
OBJECTIVETo summary the application of the extended free lateral arm flaps for buccal soft tissue reconstruction after buccal cancer.
METHODSFrom January to August 2011, three patients underwent the operation of buccal defect reconstruction using the extended free lateral arm flap in one-stage. PRCA was identification with the Doppler probe. According to the mark of PRCA, size and shape of defects, the flaps were designed and extended to the lateral epicondyle of humerus. The flap size ranged from 9 cm x 5 cm to 10 cm x 6 cm with a pedicle of 10 cm in length. The wounds at donor sites were closed directly.
RESULTSVascular crisis happened in one case due to local negative pressure, which resolved after emergency management. All the flaps survived completely. The patients were followed up for 6 to 10 months with no recurrence. Both the esthetic and functional results were satisfactory. Two cases suffered from numb feeling in donor sites which alleviated six months later.
CONCLUSIONSThe extended free lateral arm flap has reliable blood supply with appropriate thickness. It is an optional method for reconstruction of buccal defects after ablation of buccal cancer.
Aged ; Arm ; surgery ; Cheek ; surgery ; Facial Neoplasms ; pathology ; surgery ; Humans ; Male ; Middle Aged ; Reconstructive Surgical Procedures ; methods ; Skin Transplantation ; methods ; Surgical Flaps
10.Disequilibrium linkage between the polymorphism in exons 2, 3 and 4 of the MICA gene and HLA-B antigen of patient with ankylosing spondylitis.
Hong SU ; Bao-long WANG ; Xiu-jun ZHANG ; Jia-hu HAO ; Qin XIAO ; Dong-qing YE
Chinese Journal of Medical Genetics 2006;23(4):446-448
OBJECTIVETo investigate the association between the exons 2 to 4 of the MICA gene and ankylosing spondylitis (AS).
METHODSBy PCR-SSOP, DNA samples from 56 AS patients and 112 random healthy individuals, as normal control were genotyped to analyse the polymorphism in exons 2, 3, 4 of the MICA alleles.
RESULTSMICA*008 was dominant in MICA allele,accounted for 32.14% and 30.36% in AS patients and normal controls respectively. The frequency of MICA*007 was significantly increased in AS patients, when compared with normal controls (chi-square=10.18, P<0.05, RR=2.50). No difference was found in the other MICA alleles. The haplotype analysis revealed that there were the strong linkage disequilibrium between MICA and HLA-B of AS patients, and normal controls. There was a difference in MICA*007-B27 between two groups (chi-square=18.46, P<0.05, RR=7.47). Both HLA-B27 and MICA*007 were strongly associated with AS. Stratified analysis showed that HLA-B27 was significantly relative to AS,while it was not found between MICA*007 and AS.
CONCLUSIONThe increased frequency of MICA alleles may be due to its strong linkage disequilibrium with HLA-B27.
Alleles ; Exons ; genetics ; Gene Frequency ; Genotype ; HLA-B Antigens ; genetics ; HLA-B27 Antigen ; genetics ; Histocompatibility Antigens Class I ; genetics ; Humans ; Linkage Disequilibrium ; genetics ; Polymerase Chain Reaction ; Polymorphism, Genetic ; genetics ; Spondylitis, Ankylosing ; genetics